LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces the resignation of James McCullough, as a non-executive director of the company, with effect from 24 October 2024. James McCullough has taken the decision to step down from the Board to focus on his Executive role at Renalytix plc. Following this […]
Further to the Company’s announcement on 04 October 2024, LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, confirms that it has now completed the cancellation and re-issue of certain options as detailed in that announcement. As two of the affected option holders are persons discharging managerial responsibilities, dealings disclosures for […]
LungLife AI licensure/accreditation information posted here.